In order to be able to ‘select’ an embryo – we need to first understand IVF, as this is the process that gives rise to embryos in a laboratory setting.
The process of IVF involves using hormones to stimulate a woman’s ovaries to produce a number of eggs in one menstrual cycle. While a natural cycle would only typically produce one mature egg (that is able to be fertilised by sperm), IVF aims to increase this number. The number of eggs collected from an IVF cycle varies from 1-20ish. There are a number of variables that influence this number including the woman’s age, ovarian reserve, response to treatment and luck (even though this is not officially science!)
It is important to know that the number of eggs doesn’t always equate the the same number of embryos. I like to think of IVF like a hurdles race – the stumbling block being that once you miss a hurdle you are out of the race.
Eggs are collected from a woman ovaries by a specialist IVF doctor. These eggs are then ‘introduced’ to a sperm sample from the proposed father or donor. There are 2 Fertilisation techniques.
A large majority of IVF, and all PGD is done using ICSI and in general, fertilisation rates are higher using this technique. However, with all invasive techniques come minor increases in risk of adverse outcome. So doctors are always weighing up the risks with the benefits.
In the case of embryo selection there are 2 main ways an embryologist (this is a scientist that is specialised in creating and supporting the growth of embryos) can ‘select’ an embryo.
Visually – new technologies called an Embryoscope gives real-time visualisation and tracking of an embryos growth in the laboratory. Embryos are usually grown 5 days until they contain more than 100 cells – this growth stage is called blastocyst – embryos are graded and sorted for potential transfer back to a woman uterus. Typically only 1 embryo will be put back at a time to reduce the risk of multiple pregnancies. Any additional are frozen using technique called vitrification. Embryos are stable in this state and a generally stored for future us by the couple.
Preimplantation Genetic Screening (PGS) is used to assess the chromosome make-up of the embryo. We know that most early miscarriages are due to chromosome errors. An example of this is down syndrome – where an embryo inherits 3 copies of chromosome 21, instead of the regular 2 copies. Any chromosome imbalances in an embryo increase the risk of miscarriage and will lead to pregnancy complications and abnormal birth outcomes.
Preimplantation Genetic Diagnosis (PGD) is used to screen embryos for specific single gene faults that are known to be carried by the parent or parents having IVF treatment. Scientists create a unique DNA fingerprint of the specific faulty gene in the family. By comparing the DNA fingerprint of the biopsied embryos to the DNA fingerprint of the family members it is possible to determine which embryos have inherited the disease and which are free of the disorder. Unaffected embryos will then be available for IVF treatment in future cycles with a chance that it will produce a successful pregnancy and a healthy baby.
Zoë is a co-founder at Eugene and has been counselling couples in reproductive genetics for over 10 years. She is passionate about improving access to ethical genetic testing in a emotionally supportive and culturally sensitive environment. Zoe wants to empower people with knowledge of the genetic identity rather than fear it.
Can't wait till Eugene is shipping? You know what, us too! Sign up below and we'll send you exclusive early-bird access and pricing. Our tests begin shipping mid-2018.
Eugene's pre-pregnancy carrier test is like a checkup to see if you or your partner are carrying any genetic disease that could be passed on to your children.Learn more
In order to be able to ‘select’ an embryo – we need to first understand IVF, as this is the process that gives rise to embryos in a laboratory setting. […]